Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
Mahil, S
; Yiu, Z
; Mason, K
; Dand, N; Coker, B; Wall, D; Fletcher, G; Bosma, A; Capon, F
; Iversen, L
; +13 more...Langan, S
; Di Meglio, P; Musters, A; Prieto-Merino, D
; Tsakok, T; Warren, R; Flohr, C
; Spuls, P; Griffiths, C; Barker, J; Irvine, A
; Smith, C; Secure-AD and PsoProtect study groups and
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.
Item Type | Article |
---|---|
Elements ID | 147445 |
Date Deposited | 07 May 2020 12:03 |
ORCID: https://orcid.org/0000-0003-4913-1522
ORCID: https://orcid.org/0000-0002-1831-074X
ORCID: https://orcid.org/0000-0002-5419-0669
ORCID: https://orcid.org/0000-0003-2432-5793
ORCID: https://orcid.org/0000-0003-1816-4508
ORCID: https://orcid.org/0000-0002-7022-7441
ORCID: https://orcid.org/0000-0001-5001-0061
ORCID: https://orcid.org/0000-0003-4884-6286
ORCID: https://orcid.org/0000-0002-9048-2044